Hektas Ticaret T.A.S. (IBSE:HEKTS) decided to acquire ARMA ILAÇ on December 31, 2020.Hektas Ticaret T.A.S. (IBSE:HEKTS) agreed to acquire ARMA ILAÇ from OYAK BIYOTEKNOLOJI for TRY 92 million on July 28, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.5 TRY | +1.28% | -1.10% | -32.84% |
1st Jan change | Capi. | |
---|---|---|
-32.84% | 1.04B | |
+6.80% | 35.67B | |
-.--% | 11.49B | |
-13.10% | 6.84B | |
+3.62% | 6.61B | |
-3.21% | 6.04B | |
-9.30% | 5.86B | |
-11.47% | 5.24B | |
+28.21% | 5.06B | |
-6.02% | 4.96B |
- Stock Market
- Equities
- HEKTS Stock
- News Hektas Ticaret T.A.S.
- Hektas Ticaret T.A.S. decided to acquire ARMA ILAÇ from OYAK BIYOTEKNOLOJI for TRY 92 million.